<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">346459</id>
  <title nil="true"/>
  <common-name>2-[[5-(4-tert-butylphenyl)-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]-n-[(e)-[(e)-3-(furan-2-yl)prop-2-enylidene]amino]acetamide</common-name>
  <description>2-[[5-(4-tert-butylphenyl)-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]-n-[(e)-[(e)-3-(furan-2-yl)prop-2-enylidene]amino]acetamide is a chemical compound with the formula C27H27N5O2S. It has an average molecular weight of 485.60 g/mol.</description>
  <cas>307975-55-9</cas>
  <pubchem-id>6882175</pubchem-id>
  <chemical-formula>C27H27N5O2S</chemical-formula>
  <weight>485.6</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T09:54:45Z</created-at>
  <updated-at type="dateTime">2026-08-31T09:54:45Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC(C)(C)C1=CC=C(C=C1)C2=NN=C(N2C3=CC=CC=C3)SCC(=O)NN=CC=CC4=CC=CO4</moldb-smiles>
  <moldb-formula>C27H27N5O2S</moldb-formula>
  <moldb-inchi>InChI=1S/C27H27N5O2S/c1-27(2,3)21-15-13-20(14-16-21)25-30-31-26(32(25)22-9-5-4-6-10-22)35-19-24(33)29-28-17-7-11-23-12-8-18-34-23/h4-18H,19H2,1-3H3,(H,29,33)/b11-7+,28-17+</moldb-inchi>
  <moldb-inchikey>LKQMEKAAQKIWPY-SUOQOJQUSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">485.1885463</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>5.8</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM342352</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>2-[[5-(4-tert-butylphenyl)-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]-n-[(e)-[(e)-3-(furan-2-yl)prop-2-enylidene]amino]acetamide</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Azoles</klass>
  <subklass>Triazoles</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0296812</sync-id>
  <structure-inchikey>LKQMEKAAQKIWPY-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>404000200000808000002800000000000000000000000000000000000000000000000002000004008000002084804000000080000000002000200000000000000000000000000000000000000020800000000200000004008010100000001000010000001000000000000000800000000100000000000000000000000000004040000000800000000000200080880000010100000000400000000000000000000000001000000000080000000040000000400000000000102c00400000000800004000000000000000000000400000000000002000000200000000002000000040000000001048000000000402000000010000000040000001000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAjAAAAJgAAAIABBgBgAAAAAQMGACAAAAAE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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:45:12Z</structure-indexed-at>
</compound>
